| Biotechnology feed | All feeds
Net income fell 73% to $23.2 million, reflecting the aftermath since June when the company's... Pharma Times: Feb 19 2010 1:30AM Matching: renvela Find similar documents
today announced the U.S.
launch of Renvela (sevelamer carbonate) for oral suspension, a powder dosing option for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
Renvela is the only phosphate... Knoxville Journal: Feb 16 2010 7:24AM Matching: renvela Find similar documents
7 /PRNewswire/ -- BioTrends Research Group, Inc.
recently released its TreatmentTrends: US Nephrology, EU Nephrology, and Canadian Nephrology publications.
Each syndicated report offers comprehensive insight into the management of bone... PR Newswire: Jan 7 2010 10:29PM Matching: renvela Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
